Fulvestrant, classified under HS code 30049099, is exported to several key markets, including the United States, Belgium, Italy, the Netherlands, Russia, Brazil, Spain, and Sri Lanka. The Most-Favored-Nation (MFN) tariff rates for this HS code vary by country and are subject to change based on international trade agreements and national policies. For the most accurate and current tariff rates, it is advisable to consult the World Trade Organization's Integrated Database (IDB) and the respective national customs authorities.
Regarding preferential rates under Free Trade Agreements (FTAs) with India, these are contingent upon the specific terms of each agreement. For instance, the India-Sri Lanka Free Trade Agreement may offer reduced tariffs for pharmaceutical products like Fulvestrant. However, the applicability of such preferences depends on the product's compliance with the agreement's rules of origin and other stipulations. It is essential to review the specific FTA documents and consult with national customs authorities to determine eligibility for preferential rates.
Exemptions for essential medicines are often implemented to facilitate access to critical healthcare products. These exemptions can include reduced or zero tariffs and expedited customs procedures. The classification of Fulvestrant as an essential medicine and the corresponding exemptions are determined by national health and customs authorities. For example, the World Health Organization's Model List of Essential Medicines can influence national policies, but each country has the discretion to define its list and associated exemptions. Therefore, it is crucial to consult the national customs and health authorities of each importing country to ascertain the specific exemptions applicable to Fulvestrant.
